FindTrial
Sign In

Detox-B adjuvant

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline, Oncothyreon Canada Inc., QLT Inc., National Cancer Institute (NCI)

Conditions

Breast CancerExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerMelanoma (Skin)Recurrent Colon CancerRecurrent Pancreatic CancerRecurrent Rectal CancerStage I Pancreatic Cancer

Phase 1

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
CompletedNCT00007969
QLT Inc.Melanoma (Skin)
Start: 2000-10-31Updated: 2013-11-06
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
CompletedNCT00019006
National Cancer Institute (NCI)Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer, Recurrent Colon Cancer +11
Start: 1995-03-31Updated: 2024-03-04

Phase 3

Vaccine Therapy in Treating Women With Metastatic Breast Cancer
CompletedNCT00003638
Oncothyreon Canada Inc.Breast Cancer
Start: 1999-01-31End: 2008-12-31Target: 950Updated: 2013-03-26
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00002767
GlaxoSmithKlineMelanoma (Skin)
Start: 1996-01-31Target: 300Updated: 2014-01-06

Related Papers

Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy
Vaccines2024-03-275 citations
Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial.
2013-08-2257 citations